🇺🇸 FDA
Patent

US 8952031

Amino- and amido-aminotetralin derivatives and related compounds as mu opioid receptor antagonists

granted A61PA61P1/00A61P25/04

Quick answer

US patent 8952031 (Amino- and amido-aminotetralin derivatives and related compounds as mu opioid receptor antagonists) held by Theravance Biopharma R&D IP, LLC expires Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance Biopharma R&D IP, LLC
Grant date
Tue Feb 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P1/00, A61P25/04